Literature DB >> 1356063

Immunohistochemical markers in rat brain: colocalization of calretinin and calbindin-D28k with tyrosine hydroxylase.

J H Rogers1.   

Abstract

Many dopaminergic cells of the substantia nigra are known to contain the calcium-binding proteins calretinin and calbindin-D28k. Catecholaminergic cell groups throughout the rat brain were therefore examined by two-colour immunofluorescence to determine whether they too contained these calcium-binding proteins as well as tyrosine hydroxylase (TH). Some TH+ cell groups are mostly positive for both calretinin and calbindin, notably in the ventral tegmental area, the interfascicular nucleus, and parts of the substantia nigra. Other TH+ cell groups in the midbrain, hindbrain and hypothalamus are very diverse; different cell groups are positive for calretinin, or calbindin, or both, or neither. In the olfactory bulb, entirely separate sets of periglomerular cells are positive for TH, calretinin and calbindin. However, there is considerable heterogeneity in calcium-binding protein expression within most cell groups, even in the substantia nigra. This could be a sign that calcium-binding proteins are regulated according to aspects of neuronal activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356063     DOI: 10.1016/0006-8993(92)90998-o

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  29 in total

1.  Two GABAergic intraglomerular circuits differentially regulate tonic and phasic presynaptic inhibition of olfactory nerve terminals.

Authors:  Z Shao; A C Puche; E Kiyokage; G Szabo; M T Shipley
Journal:  J Neurophysiol       Date:  2009-02-18       Impact factor: 2.714

2.  Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.

Authors:  Lachlan Thompson; Perrine Barraud; Elin Andersson; Deniz Kirik; Anders Björklund
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

3.  Calretinin immunoreactivity in human sympathetic ganglia.

Authors:  J J Huerta; S Nori; M M Llamosas; M T Vázquez; E Bronzetti; J A Vega
Journal:  Anat Embryol (Berl)       Date:  1996-10

Review 4.  Calcium-binding proteins: selective markers of nerve cells.

Authors:  C Andressen; I Blümcke; M R Celio
Journal:  Cell Tissue Res       Date:  1993-02       Impact factor: 5.249

5.  Brain-derived neurotrophic factor signaling does not stimulate subventricular zone neurogenesis in adult mice and rats.

Authors:  Rui P Galvão; José Manuel Garcia-Verdugo; Arturo Alvarez-Buylla
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

6.  The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons.

Authors:  J Rodriguez-Pallares; J A Parga; B Joglar; M J Guerra; J L Labandeira-Garcia
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

7.  Mapping of the colocalization of calretinin and tyrosine hydroxylase in the rat substantia nigra and ventral tegmental area.

Authors:  K R Isaacs; D M Jacobowitz
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

Review 8.  Functional diversity of ventral midbrain dopamine and GABAergic neurons.

Authors:  Tatiana M Korotkova; Alexei A Ponomarenko; Ritchie E Brown; Helmut L Haas
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

Review 9.  An update on the connections of the ventral mesencephalic dopaminergic complex.

Authors:  L Yetnikoff; H N Lavezzi; R A Reichard; D S Zahm
Journal:  Neuroscience       Date:  2014-04-13       Impact factor: 3.590

10.  Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrain.

Authors:  Davor Stanic; Gustavo Paratcha; Fernanda Ledda; Herbert Herzog; Alan S Kopin; Tomas Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.